Related Experiment Video
Updated: Aug 8, 2026
06:27
Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy
Christoph Sucker1, Gerd Ruediger Hetzel, Bernd Grabensee
1Department of Hemostasis, Heinrich Heine University Medical Center, Duesseldorf, Germany. sucker@med.uni-duesseldorf.de
Summary
Amyloid diseases can cause dangerous bleeding due to various factors like light-chain amyloidosis or amyloid deposition in organs. Treatment depends on the specific cause, ranging from supportive care to addressing hemostatic defects.
Area of Science:
- Hematology
- Pathology
Background:
- Amyloid diseases are linked to life-threatening hemorrhage.
- Bleeding risks are diverse, influenced by amyloidosis type and organ involvement.
Purpose of the Study:
- To review the pathophysiology, diagnosis, and treatment of bleeding in amyloid diseases.
- To summarize current concepts regarding bleeding risks in amyloidosis.
Main Methods:
- Literature review of amyloidosis and associated bleeding complications.
- Discussion of pathogenetic factors, clinical manifestations, and therapeutic strategies.
Main Results:
- Light-chain (AL) amyloidosis often involves acquired hemostatic abnormalities (coagulation factor deficiencies, hyperfibrinolysis, platelet dysfunction).
- Other amyloidosis types may present with bleeding due to amyloid deposition, amyloid angiopathy, or organ rupture.
- Therapeutic approaches vary from supportive measures and surgery for local deposition to mechanism-based treatment for hemostatic defects.
Conclusions:
- Understanding the heterogeneous causes of bleeding in amyloidosis is crucial for appropriate management.
- Tailored treatment strategies are necessary, addressing either hemostatic defects or complications of amyloid deposition.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...